EquityZen Growth Technology Fund LLC - Series 1709
Raised
$555K
Investors
18
Min Invest
$4,671
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1709 is a Delaware LLC filed by EquityZen Advisors LLC and Philip Haslett under Rule 506(b) and Section 3(c)(1). The fund raised $555K from 18 investors with a $5K minimum investment. This is part of EquityZen's platform, which operates approximately 150 related EDGAR entities offering access to private equity investments.
This filing represents a typical special purpose vehicle structure within the private equity category, using the 506(b) exemption to target accredited investors without general solicitation. The $5K minimum is relatively accessible compared to traditional private equity funds, consistent with EquityZen's platform model of pooling smaller investors for access to pre-IPO companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
